Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (81-90 of 937) with videos related to

Pageof 94
Sort By:
Neuro-Oncology Practice|June 3, 2015
Corticosteroid use in neuro-oncology: an updatePatrick Roth, Caroline Happold, Michael Weller
The Lancet. Oncology|September 1, 2012
Epilepsy meets cancer: when, why, and what to do about it?Michael Weller, Roger Stupp, Wolfgang Wick
Oncology Research and Treatment|June 5, 2016
Immunotherapy of Brain CancerPatrick Roth, Matthias Preusser, Michael Weller
Current Neurology and Neuroscience Reports|March 22, 2017
Management of Elderly Patients with GlioblastomaPatrick Roth, Dorothee Gramatzki, Michael Weller
Current Pharmaceutical Design|February 4, 2006
Transforming growth factor-beta: a molecular target for the future therapy of glioblastomaWolfgang Wick, Ulrike Naumann, Michael Weller
Human Immunology|November 7, 2003
Express and protect yourself: the potential role of HLA-G on muscle cells and in inflammatory myopathiesHeinz Wiendl, Meike Mitsdoerffer, Michael Weller
Neuro-Oncology|July 19, 2013
Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825Michael Weller, W K Alfred Yung
Biochemical Pharmacology|December 27, 2016
The network of immunosuppressive pathways in glioblastomaDavide Mangani, Michael Weller, Patrick Roth
Glia|May 6, 2003
Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexinsJohannes Rieger, Wolfgang Wick, Michael Weller
Expert Review of Anticancer Therapy|September 7, 2016
Immunological effects of chemotherapy and radiotherapy against brain tumorsTobias Weiss, Michael Weller, Patrick Roth
Pageof 94

Showing results (81-90 of 937) with videos related to

Sort By:
Pageof 94
Neuro-Oncology Practice|June 3, 2015
Corticosteroid use in neuro-oncology: an updatePatrick Roth, Caroline Happold, Michael Weller
The Lancet. Oncology|September 1, 2012
Epilepsy meets cancer: when, why, and what to do about it?Michael Weller, Roger Stupp, Wolfgang Wick
Oncology Research and Treatment|June 5, 2016
Immunotherapy of Brain CancerPatrick Roth, Matthias Preusser, Michael Weller
Current Neurology and Neuroscience Reports|March 22, 2017
Management of Elderly Patients with GlioblastomaPatrick Roth, Dorothee Gramatzki, Michael Weller
Current Pharmaceutical Design|February 4, 2006
Transforming growth factor-beta: a molecular target for the future therapy of glioblastomaWolfgang Wick, Ulrike Naumann, Michael Weller
Human Immunology|November 7, 2003
Express and protect yourself: the potential role of HLA-G on muscle cells and in inflammatory myopathiesHeinz Wiendl, Meike Mitsdoerffer, Michael Weller
Neuro-Oncology|July 19, 2013
Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825Michael Weller, W K Alfred Yung
Biochemical Pharmacology|December 27, 2016
The network of immunosuppressive pathways in glioblastomaDavide Mangani, Michael Weller, Patrick Roth
Glia|May 6, 2003
Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexinsJohannes Rieger, Wolfgang Wick, Michael Weller
Expert Review of Anticancer Therapy|September 7, 2016
Immunological effects of chemotherapy and radiotherapy against brain tumorsTobias Weiss, Michael Weller, Patrick Roth
Pageof 94